Bioworld Financial Watch articles from June 2003

Bioworld Financial Watch archives from June 2003

Remicade gaining favor as IBD therapy; other targets explored.
June 2, 2003... When writer Jonathan Ames remarked in print that he suffered from "infuriated bowel syndrome," the remark might have been amusing but also was full of painful meaning - especially for the legions afflicted with the condition under its more...

10 Biggest U.S. Gainers & Losers for the Week.
June 2, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) IntraBiotics 101.62 Nanogen 71.08 Orchid 63.95 NaPro Biother 61.90 Cel-Sci 56.41 Sangamo 53.33 Allos 51.58 VaxGen...

Biotech Mergers And Acquisitions: Feb. 27-May 28, 2003 #.
June 2, 2003... Biotech Mergers And Acquisition: Feb. 27--May 28, 2003 # I. COMPLETED MERGERS AND ACQUISITIONS Acquired By Or Company Acquired * Merged With * Date Date (Country; Symbol) (Country; Symbol)...

BioWorld Stock Report for Public Biotechnology Companies.
June 2, 2003... BioWorld Stock Report For Public Biotechnology Companies Close Close %Change Vol Company Symbol 5/23 5/30 WK YTD (000) Aastrom Biosci ASTM 0.66 0.67...

London Stock Exchange.
June 2, 2003... LONDON STOCK EXCHANGE Company Symbol 5/23 5/30 %WK %YTD Volume Acambis ACM 325 343.5 5.69 24.01 1821 Antisoma ASM 29.75 36 21.01 25.22 26003 Cambridge Ab CAT...

Toronto Stock Exchange.
June 2, 2003... TORONTO STOCK EXCHANGE Company Symbol 5/23 5/30 %WK %YTD Volume Adherex AHX 0.34 0.38 11.76 -11.63 49 Angiotech Pharma ANP 39 40.76 4.51 -23.91 1196 Anormed ...

ASCO highlights strong drugs in 'multi-modal' war against cancer.
June 9, 2003... CHICAGO--"You name the diseases in medicine that we cure," said David Cunningham, lead investigator in Merck KGgA's clinical trial with Erbitux (cetuximab), which became one of the stars at this year's meeting of the American Society of...

Public financing of biotechnology: May 2003.
June 9, 2003... Public Financing Of Biotechnology: May 2003 I. COMMENCED TRADING IN MAY Company Date Date Shares/ Price Shares (Symbol) Filed Comm. Units (M) Out ...

II. Filed and pending.
June 9, 2003... II. FILED AND PENDING Company Date Shares/ Price Shares (Symbol/Proposed Filed Units Range Out Symbol) #* (M) (M) @ INITIAL OFFERINGS ViaCell Inc. ...

Other financings of public biotechnology companies: May 2003.
June 9, 2003... Other Financings Of Public Biotechnology Companies: May 2003 TOTAL: $626.134M Company Type Of Number Of Amount (Symbol) # Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: May 2003.
June 9, 2003... Venture Capital And Corporate Investments In Biotechnology Companies: May 2003 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $339.22M Company Location Date Amt. (M) 4SC AG Martinsried,...

Money raised by biotech in 2003: January - May.
June 9, 2003... Money Raised By Biotech In 2003: January - May Type of I ($M) F ($M) M ($M) A ($M) M ($M) Total ($M) financing Public offerings 254.2 81.9 169.9 87.7 33.5 627.2 Private biotechs 277.7 144.6...

BioWorld stock report for public biotechnology companies.
June 9, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change 5/30 6/6 WK YTD Aastrom Biosci ASTM 0.67 0.91 ...

Neurocrine, Sepracor race to unseat Ambien for insomnia.
June 16, 2003... With a Phase III program in full swing for its insomnia drug Indiplon (formerly NBI-34060), Neurocrine Biosciences Inc. unveiled full Phase II data for the first time during the meeting of the Associated Professional Sleep Societies earlier...

10 Biggest U.S. gainers for the week.
June 16, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEAK (By Percent) Biomira 93.83 Aastrom Biosci 59.34 Peregrine Pharma 58.54 Cyanotech 50.00 NaPro Biother 46.56 Northfield Labs 42.64 Transgene 42.22...

Clinical trial update: May 2003.
June 16, 2003... Clinical Trial Update: May 2003 Company * (Country; Symbol) Product Description AUTOIMMUNE Biogen Inc. Avonex Interferon beta-la (BGEN) (FDA-approved) ...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: May 2003.
June 16, 2003... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: May 2003 Company * Product Description (Country; Symbol) AUTOIMMUNE Cambridge Humira Adalimumab; human...

FDA Submissions, approvals and other actions: May 2003.
June 16, 2003... FDA Submissions, Approvals And Other Actions: May 2003 Company * (Country; Symbol) Product Description AUTOIMMUNE Virogenomics VG1000 Designed to target T Inc. * ...

BioWorld Stock report for public biotechnology companies.
June 16, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 6/6 6/13 WK YTD Aastrom Biosci ASTM 0.91 1.45...

London Stock Exchange.
June 16, 2003... LONDON STOCK EXCHANGE Company Symbol 6/6 6/13 %WK %YTD Volume Acambis ACM 341.5 351.5 2.93 26.90 997 Antisoma ASM 37 38.75 4.73 34.78 5731 Cambridge Ab CAT...

Toronto Stock Exchange.
June 16, 2003... TORONTO STOCK EXCHANGE Company Symbol 6/6 6/13 %WK %YTD Volume Adherex AHX 0.39 0.46 17.95 6.98 693 Angiotech Pharma ANP 44.48 54.6 22.75 1.92 2577 Anormed ...

Convertible notes gain steam as vehicle for nontypical buyers.
June 23, 2003... Forget the "open window" metaphor. Call it financing with the top down. Convertible notes are increasingly popular this summer, with more than a dozen roaring down the cash high. way so far in June. The list of issuers includes companies...

Money Raised By Biotech In 2003 Vs. 2002.
June 23, 2003... Money Raised By Biotech In 2003 Vs. 2002 Jan. 1 -- June 19, Jan. 1 -- June 20, 2003: $5,297.76M 2002: $7,200.62M Public/Other * 3,165 4,571 Private Biotechs ...

10 Biggest U.S. Gainers and Losers for the week.
June 23, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Alliance 34.78 BioReliance 2.56 LifeCell 25.56 Pharma Prod Devlp 2.05 Novavax 22.94 Immucor ...

Biotechnology Company Deals with Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, April 24--June 18, 2003.
June 23, 2003... Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, April 24-June 18, 2003 # Company * Company * (Country; (Country; Symbol) Symbol) ...

Biotechnology Company Deals with Miscellaneous Companies: Collaborations, Agreements, Equity Participation, April 24--June 18, 2003.
June 23, 2003... Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, April 24 -- June 18, 2003 # Company * Company * Type/Product Area (Country; Symbol) Acacia ...

Manufacturing, Marketing and Distribution Agreements Between Biotech Companies: April 24--June 18, 2003.
June 23, 2003... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: April 24 -- June 18, 2003 # Company * Company * (Country; (Country; Symbol) Symbol) Acadi Amarin...

Biotech--Biotech Collaborations: Modified And Terminated Agreements, April 24--June 18, 2003 #.
June 23, 2003... Biotech--Biotech Collaborations: Modified And Terminated Agreements, April 24--June 18, 2003 # I. MODIFIED AGREEMENTS Company * Company * (Country; (Country; Symbol) Symbol)...

BioWorld Stock Report Fort for Public Biotechnology Companies.
June 23, 2003... BioWorld Stock Report Fort For Public Biotechnology Companies Close Close %Change Company Symbol 6/13 6/20 WK YTD Aastrom Biosci ASTM 1.45 ...

London Stock Exchange.
June 23, 2003... LONDON STOCK EXCHANGE Company Symbol 6/13 6/20 %WK %YTD Volume Acambis ACM 351.5 363.5 3.41 31.23 2091 Aritisoms ASM 38.75 45.5 17.42 58.26 10234 Cambridge Ab...

Toronto Stock Exchange.
June 23, 2003... TORONTO STOCK EXCHANGE Company Symbol 6/13 6/20 %WK %YTD Volume Adherex AHX 0.46 0.425 -7.61 -1.16 91 Angiotech Pharma ANP 54.6 53.5 -2.01 -0.13 879 Anormed ...

Burrill report projects optimism for the biotechnology industry.
June 30, 2003... WASHINGTON -- As biotech emerges from the wreckage of what G. Steven Burrill calls the "Sam and Martha sideshow," and as uncertainties over war in Iraq, the new requirements of financial reporting and devalued market capitalizations continue to...

Biotech Corporate Collaborations in Agriculture: New, Revised Agreements, Nov. 27, 2002 - June 26, 2003.
June 30, 2003... Biotech Corporate Collaborations In Agriculture: New, Revised Agreements, Nov. 27, 2002 - June 26, 2003# Biotech Co. * Agbiotech (Country: Partner (Country: Symbol) Symbol) ...

BioWorld Stock Report for Public Biotechnology Companies.
June 30, 2003... BioWorld Stock Report For Public Biotechnology Companies Close Close Change Company Symbol 6/20 6/27 WK YTD Aastrom Biosci ASTM 1.19 1.06 ...

10 Biggest U.S. Gainers and Losers for the Week.
June 30, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Deltagen 34.78 Esperion 3.66 Northwest BioThera 33.33 Gilead Sciences 2.56 Carrington 33.17 ILEX Oncology 2.42...

Money Raised By Biotech In 2003 Vs. 2002.
June 30, 2003... Money Raised By Biotech In 2003 Vs. 2002 Jan. 1 - June 26, 2003: Jan. 1 - June 27, 2002: $5,559.45M $7,374.17M Public/Other * 3,352 4,596...